Merck, a leading science and technology company, today launched a beta version of M-Trust™, a secure cyber-physical trust ...

Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair (sotatercept) for adult patients with pulmonary arterial hypertension (PAH).

There is plenty to like about Merck ( MRK -0.17%). It is one of the largest pharmaceutical companies and the owner of the ...

Merck, a leading science and technology company, announced the closing of the transaction to acquire HUB Organoids Holding ...

We recently compiled a list of the 10 Best Stocks to Buy According to Billionaire D.E. Shaw. In this article, we are going to ...

Shares of Merck & Co. Inc ($MRK) were in the spotlight this week after the pharmaceutical major secured regulatory approval ...

WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...

Shares of Merck & Co. Inc. MRK slumped 0.31% to $99.17 Thursday, on what proved to be an all-around dismal trading session ...

Merck, a leading global pharmaceutical company that produces a range of medicines, vaccines, and animal healthcare products, is now a $258 billion (by market cap) healthcare behemoth. The US is ...

has reassured investors of the company’s future potential despite short-term challenges. Merck also faced challenges with some of its other products. Sales of its type 2 diabetes drug Januvia ...

UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's therapy to treat a rare lung ...

Merck & Company (MRK) Company Description: Merck & Co., Inc. develops pharmaceutical and vaccine products. It also offers healthcare solutions and vaccines addressing animal health. The company ...